Oppenheimer stays Outperform on BioAge Labs Inc (BIOA) following Q4 earnings update
Tweet Send to a Friend
Oppenheimer analyst Jay Olson reiterated an Outperform rating and $60.00 price target on BioAge Labs Inc (NASDAQ: BIOA)The analyst commented ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
